Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Change in Interest of Substantial Shareholder - Shenzhen Sichuang Meishi Pharmaceuticals R&D

Issuer & Securities

Issuer/ Manager
PHARMESIS INTERNATIONAL LTD.
Securities
PHARMESIS INTERNATIONAL LTD. - SG1BH6000003 - BFK
Stapled Security
No

Announcement Details

Announcement Title
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)
Date &Time of Broadcast
11-Apr-2023 23:36:19
Status
New
Announcement Sub Title
Change in Interest of Substantial Shareholder - Shenzhen Sichuang Meishi Pharmaceuticals R&D
Announcement Reference
SG230411OTHRQQPZ
Submitted By (Co./ Ind. Name)
Wu Xuedan
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Please refer to the attached.

Additional Details

Person(s) giving notice
Substantial Shareholder(s)/Unitholder(s) (Form 3)
Date of receipt of notice by Listed Issuer
10/04/2023

Attachments

20230405 - eFORM3V2 - Shenzhen Sichuang - Pharmesis.pdf
if you are unable to view the above file, please click the link below.
_20230405 - eFORM3V2 - Shenzhen Sichuang - Pharmesis.pdf
Total size =203K